Page last updated: 2024-09-03

vadimezan and Bone Cancer

vadimezan has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bang, S; Donnelly, CR; Hilton, MJ; Ji, RR; Jiang, C; Lee, M; Liao, Y; Luo, X; McGinnis, A; Tao, X; Wang, K1
Cathomas, R; Erdmann, A; Früh, M; Fustier, P; Krasniqi, F; Küttel, E; Mamot, C; Pless, M; Rauch, D; Siano, M; Simcock, M; Tscherry, G; Zippelius, A1

Trials

1 trial(s) available for vadimezan and Bone Cancer

ArticleYear
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08).
    Clinical lung cancer, 2013, Volume: 14, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Small Cell Lung Carcinoma; Treatment Outcome; Xanthones

2013

Other Studies

1 other study(ies) available for vadimezan and Bone Cancer

ArticleYear
STING suppresses bone cancer pain via immune and neuronal modulation.
    Nature communications, 2021, 07-27, Volume: 12, Issue:1

    Topics: Analgesics; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Femur; Ganglia, Spinal; Homeodomain Proteins; Hyperalgesia; Interferons; Male; Mammary Neoplasms, Animal; Membrane Proteins; Mice, Inbred C57BL; Neoplasm Metastasis; Neurons; Nociception; Osteoclasts; Osteogenesis; Receptor, Interferon alpha-beta; Signal Transduction; Tumor Burden; Tumor Microenvironment; Xanthones

2021